Susman Sally's Form 4 filing
Pfizer Inc (PFE) · filed Nov 30, 2021
- Accession no.
- 0001225208-21-014219
- Filed
- Nov 30, 2021
- Trade date
- Nov 26, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 14 non-derivative transactions. Open-market sales total $2.42M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Susman SallyCIK 0001263544 | Officer (Executive Vice President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 26, 2021 | Common Stock | SSaleDisposed | −58 | $54.43 | −$3,156.94 | 133,825 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −101 | $54.48 | −$5,502.48 | 133,724 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −250 | $54.57 | −$13,642.5 | 133,474 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −399 | $54.53 | −$21,757.47 | 133,075 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −400 | $54.51 | −$21,804 | 132,675 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −700 | $54.50 | −$38,150 | 131,975 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −700 | $54.49 | −$38,143 | 131,275 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −800 | $54.47 | −$43,576 | 130,475 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −901 | $54.56 | −$49,158.56 | 129,574 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −1,130 | $54.65 | −$61,754.5 | 128,444 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −2,279 | $54.45 | −$124,091.55 | 126,165 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −3,700 | $54.55 | −$201,835 | 122,465 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −12,370 | $54.64 | −$675,896.8 | 110,095 | Direct | |
| Nov 26, 2021 | Common Stock | SSaleDisposed | −20,520 | $54.44 | −$1,117,108.8 | 89,575 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.